

Reporting a possible serious reactionĬontact your health care provider if you experience: This vaccine does not contain common food allergens, such as eggs, shellfish, gluten or nuts. Talk to your doctor if you have a severe allergy to one of the ingredients contained in the vaccine.
#HEALTH BENEFITS OF DMG SKIN#
hives (bumps on the skin that are often very itchy).Signs and symptoms of anaphylaxis may include: Rare reactions that have been reported and confirmed after taking an mRNA vaccine are:Ī severe allergic (anaphylaxis) reaction is also rare. Common vaccine side effects may include: Symptoms at the injection site, such as: This is the body's natural response, as it's working hard to build protection against the disease. These can last a few hours to a few days after vaccination. 1,2-Distearoyl-sn-glycero-3-phosphocholineĪfter getting vaccinated, it's common to have temporary side effects.The National Advisory Committee on Immunization (NACI) recommends an mRNA vaccine (Pfizer-BioNTech Comirnaty® or Moderna Spikevax®) should be offered for your second dose. For example, you may have received Pfizer-BioNTech Comirnaty® as your first dose and be offered Moderna Spikevax® as your second. Find out how provinces and territories are making COVID-19 vaccine decisionsĪ different vaccine may be offered for your second dose.These decisions are based on public health recommendations and the latest evidence. Your province or territory decides when people receive their first and second doses of the vaccine. The dosing schedule approved by Health Canada is to give the 2 doses one month apart, based on evidence from clinical trials. This vaccine requires 2 doses for maximum protection.

#HEALTH BENEFITS OF DMG TRIAL#
100% effective in trial participants 12 to 17 years old.94.1% effective in protecting trial participants aged 18 and above against COVID-19.EffectivenessĬlinical trials showed that beginning 2 weeks after the second dose, the Moderna Spikevax® COVID vaccine was: Its safety and effectiveness in people younger than 12 years of age have not yet been established. The vaccine is approved for people who are 12 years of age and older.

